TLC BioSciences Corp. (TPEX:7924)
Taiwan · Delayed Price · Currency is TWD 250.50
-12.50 (-4.75%)
At close: Jul 8, 2026
TLC BioSciences Market Cap
TLC BioSciences has a market cap or net worth of 32.86 billion as of July 9, 2026.
Market Cap
32.86B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
250.50
Market Cap Chart
Since June 26, 2026, TLC BioSciences's market cap has increased from 28.11B to 32.86B, an increase of 16.86%. That is a compound annual growth rate of 7,849.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 32.86B | -1.80% |
| Jul 8, 2026 | 33.46B | -4.75% |
| Jul 7, 2026 | 35.13B | 8.68% |
| Jul 6, 2026 | 32.32B | -3.59% |
| Jul 3, 2026 | 33.52B | 48.52% |
| Jul 2, 2026 | 22.57B | -4.52% |
| Jul 1, 2026 | 23.64B | -8.05% |
| Jun 30, 2026 | 25.71B | -10.26% |
| Jun 29, 2026 | 28.65B | 1.90% |
| Jun 26, 2026 | 28.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 20.28B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.95B |
| Tripartite Therapeutics | 8.05B |
| Uwell Biopharma | 7.23B |
| Intelligene | 6.41B |
| Obigen Pharma | 3.86B |
| Pet Pharm Biotech | 3.03B |
| BIONET Therapeutics | 2.48B |